Live Quote · OTCPVCTHealthcare· Biotechnology

Provectus Biopharmaceuticals, Inc.

$0.07 0.43%($-0.00)
TickerSpark Score
51/100
Mixed
47
Valuation
60
Profitability
10
Growth
36
Health
100
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PVCT research report →

52-Week Range46% of range
Low
$0.04
Current
$0.07
High
$0.10
Company Overviewwww.provectusbio.com

About the company

Provectus Biopharmaceuticals, Inc. is a clinical-stage biotechnology firm dedicated to pioneering immunotherapy treatments. These therapies are grounded in its proprietary halogenated xanthene platform.

CEO
Edward V. Pershing
IPO
1997
Employees
6
HQ
Knoxville, TN, US

Price Chart

-6.76% · this period
$0.10$0.07$0.04Jul 02Dec 31Jul 02
Valuation
Market Cap
$29.00M
P/E
-5.19
P/S
504.51
P/B
-4.31
EV/EBITDA
-6.19
Div Yield
0.00%
Profitability
Gross Margin
96.76%
Op Margin
-8867.49%
Net Margin
-9775.33%
ROE
89.65%
ROIC
128.59%
Growth & Income
Revenue
$336.11K · -45.54%
Net Income
$-5,430,851 · -14.74%
EPS
$-0.01 · -14.16%
Op Income
$-4,844,269
FCF YoY
-1.28%
Performance & Tape
52W High
$0.10
52W Low
$0.04
50D MA
$0.06
200D MA
$0.06
Beta
0.83
Avg Volume
157.92K

Get TickerSpark's AI analysis on PVCT

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Jun 30, 26Pershing Edwardother45,860
Jun 30, 26Rodrigues Dominicother45,860
Jun 30, 26Lacey John IIIother48,917
Jun 30, 26Bailey Websterother48,917
Jun 5, 26Pershing Edwardother9,436
Jun 5, 26Pershing Edwardother0
May 28, 26Pershing Edwardother0
May 23, 26Pershing Edwardother32,089
May 23, 26Pershing Edwardother0
May 15, 26Pershing Edwardother22,651
Coverage · PVCT

Our PVCT coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on PVCT yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate PVCT report →
Internal Compare

Similar companies

Peers in the same neighborhood.